DNA hyperploidy as a marker for biological response to bladder carcinogen exposure
- 30 November 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 42 (6) , 817-820
- https://doi.org/10.1002/ijc.2910420602
Abstract
A marker for biological response to bladder carcinogen exposure was evaluated in a cross‐sectional study of 504 workers at high risk due to a range of exposures to various carcinogenic aromatic amines, primarily 2‐naphthylamine. A quantitative fluorescence cytology method using the DNA‐binding dye, acridine orange, was employed to measure DNA in exfoliated urothelial cells. DNA hyperploidy (>5 C) was observed in 16 (21.6%) of 74 workers who had been exposed compared with 15 (3.5%) of 430 workers who had not (p < 0.001). The prevalence of DNA hyperploidy increased in a dose‐response manner from 3.5% to 60% with increasing duration of exposure. The association between DNA hyperploidy and exposure persisted when adjustment was made for age and cigarette smoking (p = 0.0001). The prevalence of the marker was greatest for exposed workers who smoked (23%), and lowest for those who had no exposure and who had not smoked (2%). This study indicates that DNA hyperploidy can serve as a marker for identifying workers who are at increased risk in occupational groups exposed to bladder carcinogens.This publication has 13 references indexed in Scilit:
- DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patientsInternational Journal of Cancer, 1987
- Risk factors for bladder cancer in a cohort exposed to aromatic aminesCancer, 1986
- Optimal Management of Asymptomatic Workers at High Risk of Bladder CancerJournal of Occupational and Environmental Medicine, 1986
- Quantitative fluorescence measurements of ao-stained normal and malignant bladder cellsInternational Journal of Cancer, 1983
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- BLADDER CANCER EPIDEMIOLOGY1Epidemiologic Reviews, 1981
- BETA‐NAPHTHYLAMINE AND BENZIDINE: IDENTIFICATION OF GROUPS AT HIGH RISK OF BLADDER CANCERAnnals of the New York Academy of Sciences, 1979
- N-ACETYLTRANSFERASE PHENOTYPE AND RISK IN INDUSTRIAL URINARY BLADDER CANCER: APPROACHES TO HIGH RISK GROUPSPublished by Elsevier ,1979
- The Association of Smoking with Cancer of the Urinary Bladder in HumansArchives of internal medicine (1960), 1956